DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+17.89%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.61B
AUM Growth
+$2.61B
(+6%)
Cap. Flow
-$175M
Cap. Flow
% of AUM
-6.73%
Top 10 Holdings %
Top 10 Hldgs %
41.68%
Holding
110
New
10
Increased
19
Reduced
25
Closed
16
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$37.7M |
| 2 |
Alector
ALEC
|
$36.6M |
| 3 |
Axogen
AXGN
|
$35M |
| 4 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$32.6M |
| 5 |
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
|
$27.3M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$45.6M |
| 2 |
Ascendis Pharma
ASND
|
$42.5M |
| 3 |
eHealth
EHTH
|
$39.7M |
| 4 |
Vericel Corp
VCEL
|
$35.7M |
| 5 |
Tandem Diabetes Care
TNDM
|
$32.9M |
Sector Composition
| 1 | Healthcare | 68.74% |
| 2 | Financials | 1.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $171M | 6.55% | 6,462,634 -363,085 | -5% | -$9.6M |
|
2
Q32 Bio
QTTB
$20.9M
| $145M | 5.56% | 5,227,035 | – | – |
|
|
ORTX
3
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $143M | 5.5% | 8,023,600 | – | – |
|
|
PTLA
4
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $90.8M | 3.48% | 2,617,543 +940,129 | +56% | +$32.6M |
|
5
Viatris
VTRS
$12.3B
| $90.7M | 3.48% | 3,199,789 +366,048 | +13% | +$10.4M |
|
|
AERI
6
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $76.4M | 2.93% | 1,608,785 +90,189 | +6% | +$4.28M |
|
|
IMMU
7
DELISTED
Immunomedics Inc
IMMU
| $72.9M | 2.8% | 3,794,783 +1,961,581 | +107% | +$37.7M |
|
|
XENT
8
DELISTED
Intersect ENT, Inc
XENT
| $64.5M | 2.47% | 2,005,964 -72,411 | -3% | -$2.33M |
|
|
XLRN
9
DELISTED
Acceleron Pharma Inc.
XLRN
| $58.5M | 2.24% | 1,255,174 -131,367 | -9% | -$6.12M |
|
10
AnaptysBio
ANAB
$569M
| $54.3M | 2.08% | 743,439 | – | – |
|
11
BioCryst Pharmaceuticals
BCRX
$1.74B
| $53.2M | 2.04% | 6,537,566 -373,223 | -5% | -$3.04M |
|
|
MYOK
12
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $51.8M | 1.99% | 997,000 | – | – |
|
13
argenx
ARGX
$43.6B
| $49.2M | 1.88% | 393,750 -78,250 | -17% | -$9.77M |
|
14
Sarepta Therapeutics
SRPT
$1.78B
| $46M | 1.76% | 386,000 +44,200 | +13% | +$5.27M |
|
|
DPLO
15
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $41M | 1.57% | 7,049,297 +4,700,304 | +200% | +$27.3M |
|
|
BPMC
16
DELISTED
Blueprint Medicines
BPMC
| $40.6M | 1.56% | 506,865 -14,135 | -3% | -$1.13M |
|
|
17
Axogen
AXGN
$743M
| $37.2M | 1.43% | 1,767,006 +1,662,332 | +1,588% | +$35M |
|
|
18
Alector
ALEC
$238M
| $36.6M | 1.4% | +1,956,923 | New | +$36.6M |
|
|
NVRO
19
DELISTED
NEVRO CORP.
NVRO
| $36.2M | 1.39% | 579,463 -334,810 | -37% | -$20.9M |
|
20
Centene
CNC
$14.3B
| $35.4M | 1.36% | 667,000 +381,000 | +133% | +$20.2M |
|
21
Aclaris Therapeutics
ACRS
$209M
| $35.3M | 1.35% | 5,893,416 | – | – |
|
22
Brookdale Senior Living
BKD
$1.83B
| $34M | 1.3% | 5,161,355 +920,500 | +22% | +$6.06M |
|
|
RARX
23
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $33.6M | 1.29% | 1,502,000 | – | – |
|
|
RETA
24
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $31.1M | 1.19% | 364,000 | – | – |
|
25
Fate Therapeutics
FATE
$120M
| $29.9M | 1.15% | 1,702,897 +48,032 | +3% | +$844K |
|